Will cancer vaccine boost immunotherapy’s efficacy?
Rationale and status reports on mechanistically diverse strategies
No evidence of residual tumor or recurrence at 6.5 years of follow-up
Drug stimulates an immune response to survivin
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First new medical intervention in a decade to demonstrate improved survival
Radiation plus targeted therapy improves survival rates
Inhibitor stops DNA repair of cancer cells
Clinical approaches in the era of targeted therapy
Therapy targets radiation-resistant glioma stem cells
Study confirms importance of tumor’s molecular profile